1IIL - JenaLib

Asymmetric Unit (47, 184)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017259	A	172	F	FGFR2_HUMAN	Disease (PS)	---	E/F/G/H	A	172	F
02	UniProt	VAR_017260	M	186	T	FGFR2_HUMAN	Polymorphism	755793	E/F/G/H	M	186	T
03	UniProt	VAR_036380	R	203	C	FGFR2_HUMAN	Unclassified	---	E/F/G/H	R	203	C
04	UniProt	VAR_004114	S	252	F	FGFR2_HUMAN	Disease (APRS)	121918498	E/F/G/H	S	252	F
05	UniProt	VAR_004113	S	252	L	FGFR2_HUMAN	Disease (CS)	79184941	E/F/G/H	S	252	L
06	UniProt	VAR_004115	S	252	W	FGFR2_HUMAN	Disease (PS)	79184941	E/F/G/H	S	252	W
07	UniProt	VAR_004117	P	253	R	FGFR2_HUMAN	Disease (APRS)	77543610	E/F/G/H	R	253	R
08	UniProt	VAR_017261	P	263	L	FGFR2_HUMAN	Disease (CS)	779326224	E/F/G/H	P	263	L
09	UniProt	VAR_004118	S	267	P	FGFR2_HUMAN	Disease (CS)	121918505	E/F/G/H	S	267	P
10	UniProt	VAR_042205	G	272	V	FGFR2_HUMAN	Unclassified	---	E/F/G/H	G	272	V
11	UniProt	VAR_004120	F	276	V	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	F	276	V
12	UniProt	VAR_004121	C	278	F	FGFR2_HUMAN	Disease (PS)	776587763	E/F/G/H	C	278	F
13	UniProt	VAR_017263	C	278	Y	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	C	278	Y
14	UniProt	VAR_017264	Y	281	C	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	Y	281	C
15	UniProt	VAR_042206	D	283	N	FGFR2_HUMAN	Unclassified	---	E/F/G/H	D	283	N
16	UniProt	VAR_017265	I	288	S	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	I	288	S
17	UniProt	VAR_004123	Q	289	P	FGFR2_HUMAN	Disease (JWS)	121918497	E/F/G/H	Q	289	P
18	UniProt	VAR_004124	W	290	C	FGFR2_HUMAN	Disease (PS)	121918499	E/F/G/H	W	290	C
19	UniProt	VAR_017266	W	290	G	FGFR2_HUMAN	Disease (CS)	121918501	E/F/G/H	W	290	G
20	UniProt	VAR_004125	W	290	R	FGFR2_HUMAN	Disease (CS)	121918501	E/F/G/H	W	290	R
21	UniProt	VAR_004126	K	292	E	FGFR2_HUMAN	Disease (CS)	121918500	E/F/G/H	K	292	E
22	UniProt	VAR_004127	Y	301	C	FGFR2_HUMAN	Disease (CS)	---	G/H	Y	301	C
23	UniProt	VAR_004128	A	314	S	FGFR2_HUMAN	Unclassified	---	E/F/G/H	A	314	S
24	UniProt	VAR_017267	A	315	S	FGFR2_HUMAN	Polymorphism	121918504	E/F/G/H	A	315	S
25	UniProt	VAR_004129	D	321	A	FGFR2_HUMAN	Disease (PS)	121918510	E/F/G/H	D	321	A
26	UniProt	VAR_004130	Y	328	C	FGFR2_HUMAN	Disease (CS)	121918493	E/F/G/H	Y	328	C
27	UniProt	VAR_004131	N	331	I	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	N	331	I
28	UniProt	VAR_017268	A	337	P	FGFR2_HUMAN	Disease (CS)	387906676	E/F/G/H	A	337	P
29	UniProt	VAR_004133	G	338	E	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	G	338	E
30	UniProt	VAR_015011	G	338	R	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	G	338	R
31	UniProt	VAR_017269	Y	340	C	FGFR2_HUMAN	Disease (PS)	---	E/F/G/H	Y	340	C
32	UniProt	VAR_004134	Y	340	H	FGFR2_HUMAN	Disease (CS)	121918489	E/F/G/H	Y	340	H
33	UniProt	VAR_004135	T	341	P	FGFR2_HUMAN	Disease (PS)	121918495	E/F/G/H	T	341	P
34	UniProt	VAR_004136	C	342	F	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	C	342	F
35	UniProt	VAR_017270	C	342	G	FGFR2_HUMAN	Disease (PS)	---	E/F/G/H	C	342	G
36	UniProt	VAR_004137	C	342	R	FGFR2_HUMAN	Disease (PS)	121918488	E/F/G/H	C	342	R
37	UniProt	VAR_004138	C	342	S	FGFR2_HUMAN	Disease (PS)	121918488	E/F/G/H	C	342	S
38	UniProt	VAR_017271	C	342	W	FGFR2_HUMAN	Disease (CS)	121918496	E/F/G/H	C	342	W
39	UniProt	VAR_004139	C	342	Y	FGFR2_HUMAN	Disease (PS)	121918487	E/F/G/H	C	342	Y
40	UniProt	VAR_004140	A	344	G	FGFR2_HUMAN	Disease (JWS)	121918492	E/F/G/H	A	344	G
41	UniProt	VAR_004141	A	344	P	FGFR2_HUMAN	Disease (PS)	---	E/F/G/H	A	344	P
42	UniProt	VAR_004142	S	347	C	FGFR2_HUMAN	Disease (CS)	121918494	E/F/G/H	S	347	C
43	UniProt	VAR_004143	S	351	C	FGFR2_HUMAN	Disease (PS)	121918502	E/F/G/H	S	351	C
44	UniProt	VAR_004144	S	354	C	FGFR2_HUMAN	Disease (CS)	121918490	E/F/G/H	S	354	C
45	UniProt	VAR_017272	S	354	Y	FGFR2_HUMAN	Disease (CS)	---	E/F/G/H	S	354	Y
46	UniProt	VAR_004146	V	359	F	FGFR2_HUMAN	Disease (PS)	---	E/F/G/H	V	359	F
47	UniProt	VAR_017273	A	362	S	FGFR2_HUMAN	Disease (CS)	---	G/H	A	362	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (45, 45)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017259	A	172	F	FGFR2_HUMAN	Disease (PS)	---	E	A	172	F
02	UniProt	VAR_017260	M	186	T	FGFR2_HUMAN	Polymorphism	755793	E	M	186	T
03	UniProt	VAR_036380	R	203	C	FGFR2_HUMAN	Unclassified	---	E	R	203	C
04	UniProt	VAR_004114	S	252	F	FGFR2_HUMAN	Disease (APRS)	121918498	E	S	252	F
05	UniProt	VAR_004113	S	252	L	FGFR2_HUMAN	Disease (CS)	79184941	E	S	252	L
06	UniProt	VAR_004115	S	252	W	FGFR2_HUMAN	Disease (PS)	79184941	E	S	252	W
07	UniProt	VAR_004117	P	253	R	FGFR2_HUMAN	Disease (APRS)	77543610	E	R	253	R
08	UniProt	VAR_017261	P	263	L	FGFR2_HUMAN	Disease (CS)	779326224	E	P	263	L
09	UniProt	VAR_004118	S	267	P	FGFR2_HUMAN	Disease (CS)	121918505	E	S	267	P
10	UniProt	VAR_042205	G	272	V	FGFR2_HUMAN	Unclassified	---	E	G	272	V
11	UniProt	VAR_004120	F	276	V	FGFR2_HUMAN	Disease (CS)	---	E	F	276	V
12	UniProt	VAR_004121	C	278	F	FGFR2_HUMAN	Disease (PS)	776587763	E	C	278	F
13	UniProt	VAR_017263	C	278	Y	FGFR2_HUMAN	Disease (CS)	---	E	C	278	Y
14	UniProt	VAR_017264	Y	281	C	FGFR2_HUMAN	Disease (CS)	---	E	Y	281	C
15	UniProt	VAR_042206	D	283	N	FGFR2_HUMAN	Unclassified	---	E	D	283	N
16	UniProt	VAR_017265	I	288	S	FGFR2_HUMAN	Disease (CS)	---	E	I	288	S
17	UniProt	VAR_004123	Q	289	P	FGFR2_HUMAN	Disease (JWS)	121918497	E	Q	289	P
18	UniProt	VAR_004124	W	290	C	FGFR2_HUMAN	Disease (PS)	121918499	E	W	290	C
19	UniProt	VAR_017266	W	290	G	FGFR2_HUMAN	Disease (CS)	121918501	E	W	290	G
20	UniProt	VAR_004125	W	290	R	FGFR2_HUMAN	Disease (CS)	121918501	E	W	290	R
21	UniProt	VAR_004126	K	292	E	FGFR2_HUMAN	Disease (CS)	121918500	E	K	292	E
23	UniProt	VAR_004128	A	314	S	FGFR2_HUMAN	Unclassified	---	E	A	314	S
24	UniProt	VAR_017267	A	315	S	FGFR2_HUMAN	Polymorphism	121918504	E	A	315	S
25	UniProt	VAR_004129	D	321	A	FGFR2_HUMAN	Disease (PS)	121918510	E	D	321	A
26	UniProt	VAR_004130	Y	328	C	FGFR2_HUMAN	Disease (CS)	121918493	E	Y	328	C
27	UniProt	VAR_004131	N	331	I	FGFR2_HUMAN	Disease (CS)	---	E	N	331	I
28	UniProt	VAR_017268	A	337	P	FGFR2_HUMAN	Disease (CS)	387906676	E	A	337	P
29	UniProt	VAR_004133	G	338	E	FGFR2_HUMAN	Disease (CS)	---	E	G	338	E
30	UniProt	VAR_015011	G	338	R	FGFR2_HUMAN	Disease (CS)	---	E	G	338	R
31	UniProt	VAR_017269	Y	340	C	FGFR2_HUMAN	Disease (PS)	---	E	Y	340	C
32	UniProt	VAR_004134	Y	340	H	FGFR2_HUMAN	Disease (CS)	121918489	E	Y	340	H
33	UniProt	VAR_004135	T	341	P	FGFR2_HUMAN	Disease (PS)	121918495	E	T	341	P
34	UniProt	VAR_004136	C	342	F	FGFR2_HUMAN	Disease (CS)	---	E	C	342	F
35	UniProt	VAR_017270	C	342	G	FGFR2_HUMAN	Disease (PS)	---	E	C	342	G
36	UniProt	VAR_004137	C	342	R	FGFR2_HUMAN	Disease (PS)	121918488	E	C	342	R
37	UniProt	VAR_004138	C	342	S	FGFR2_HUMAN	Disease (PS)	121918488	E	C	342	S
38	UniProt	VAR_017271	C	342	W	FGFR2_HUMAN	Disease (CS)	121918496	E	C	342	W
39	UniProt	VAR_004139	C	342	Y	FGFR2_HUMAN	Disease (PS)	121918487	E	C	342	Y
40	UniProt	VAR_004140	A	344	G	FGFR2_HUMAN	Disease (JWS)	121918492	E	A	344	G
41	UniProt	VAR_004141	A	344	P	FGFR2_HUMAN	Disease (PS)	---	E	A	344	P
42	UniProt	VAR_004142	S	347	C	FGFR2_HUMAN	Disease (CS)	121918494	E	S	347	C
43	UniProt	VAR_004143	S	351	C	FGFR2_HUMAN	Disease (PS)	121918502	E	S	351	C
44	UniProt	VAR_004144	S	354	C	FGFR2_HUMAN	Disease (CS)	121918490	E	S	354	C
45	UniProt	VAR_017272	S	354	Y	FGFR2_HUMAN	Disease (CS)	---	E	S	354	Y
46	UniProt	VAR_004146	V	359	F	FGFR2_HUMAN	Disease (PS)	---	E	V	359	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (45, 45)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017259	A	172	F	FGFR2_HUMAN	Disease (PS)	---	F	A	172	F
02	UniProt	VAR_017260	M	186	T	FGFR2_HUMAN	Polymorphism	755793	F	M	186	T
03	UniProt	VAR_036380	R	203	C	FGFR2_HUMAN	Unclassified	---	F	R	203	C
04	UniProt	VAR_004114	S	252	F	FGFR2_HUMAN	Disease (APRS)	121918498	F	S	252	F
05	UniProt	VAR_004113	S	252	L	FGFR2_HUMAN	Disease (CS)	79184941	F	S	252	L
06	UniProt	VAR_004115	S	252	W	FGFR2_HUMAN	Disease (PS)	79184941	F	S	252	W
07	UniProt	VAR_004117	P	253	R	FGFR2_HUMAN	Disease (APRS)	77543610	F	R	253	R
08	UniProt	VAR_017261	P	263	L	FGFR2_HUMAN	Disease (CS)	779326224	F	P	263	L
09	UniProt	VAR_004118	S	267	P	FGFR2_HUMAN	Disease (CS)	121918505	F	S	267	P
10	UniProt	VAR_042205	G	272	V	FGFR2_HUMAN	Unclassified	---	F	G	272	V
11	UniProt	VAR_004120	F	276	V	FGFR2_HUMAN	Disease (CS)	---	F	F	276	V
12	UniProt	VAR_004121	C	278	F	FGFR2_HUMAN	Disease (PS)	776587763	F	C	278	F
13	UniProt	VAR_017263	C	278	Y	FGFR2_HUMAN	Disease (CS)	---	F	C	278	Y
14	UniProt	VAR_017264	Y	281	C	FGFR2_HUMAN	Disease (CS)	---	F	Y	281	C
15	UniProt	VAR_042206	D	283	N	FGFR2_HUMAN	Unclassified	---	F	D	283	N
16	UniProt	VAR_017265	I	288	S	FGFR2_HUMAN	Disease (CS)	---	F	I	288	S
17	UniProt	VAR_004123	Q	289	P	FGFR2_HUMAN	Disease (JWS)	121918497	F	Q	289	P
18	UniProt	VAR_004124	W	290	C	FGFR2_HUMAN	Disease (PS)	121918499	F	W	290	C
19	UniProt	VAR_017266	W	290	G	FGFR2_HUMAN	Disease (CS)	121918501	F	W	290	G
20	UniProt	VAR_004125	W	290	R	FGFR2_HUMAN	Disease (CS)	121918501	F	W	290	R
21	UniProt	VAR_004126	K	292	E	FGFR2_HUMAN	Disease (CS)	121918500	F	K	292	E
23	UniProt	VAR_004128	A	314	S	FGFR2_HUMAN	Unclassified	---	F	A	314	S
24	UniProt	VAR_017267	A	315	S	FGFR2_HUMAN	Polymorphism	121918504	F	A	315	S
25	UniProt	VAR_004129	D	321	A	FGFR2_HUMAN	Disease (PS)	121918510	F	D	321	A
26	UniProt	VAR_004130	Y	328	C	FGFR2_HUMAN	Disease (CS)	121918493	F	Y	328	C
27	UniProt	VAR_004131	N	331	I	FGFR2_HUMAN	Disease (CS)	---	F	N	331	I
28	UniProt	VAR_017268	A	337	P	FGFR2_HUMAN	Disease (CS)	387906676	F	A	337	P
29	UniProt	VAR_004133	G	338	E	FGFR2_HUMAN	Disease (CS)	---	F	G	338	E
30	UniProt	VAR_015011	G	338	R	FGFR2_HUMAN	Disease (CS)	---	F	G	338	R
31	UniProt	VAR_017269	Y	340	C	FGFR2_HUMAN	Disease (PS)	---	F	Y	340	C
32	UniProt	VAR_004134	Y	340	H	FGFR2_HUMAN	Disease (CS)	121918489	F	Y	340	H
33	UniProt	VAR_004135	T	341	P	FGFR2_HUMAN	Disease (PS)	121918495	F	T	341	P
34	UniProt	VAR_004136	C	342	F	FGFR2_HUMAN	Disease (CS)	---	F	C	342	F
35	UniProt	VAR_017270	C	342	G	FGFR2_HUMAN	Disease (PS)	---	F	C	342	G
36	UniProt	VAR_004137	C	342	R	FGFR2_HUMAN	Disease (PS)	121918488	F	C	342	R
37	UniProt	VAR_004138	C	342	S	FGFR2_HUMAN	Disease (PS)	121918488	F	C	342	S
38	UniProt	VAR_017271	C	342	W	FGFR2_HUMAN	Disease (CS)	121918496	F	C	342	W
39	UniProt	VAR_004139	C	342	Y	FGFR2_HUMAN	Disease (PS)	121918487	F	C	342	Y
40	UniProt	VAR_004140	A	344	G	FGFR2_HUMAN	Disease (JWS)	121918492	F	A	344	G
41	UniProt	VAR_004141	A	344	P	FGFR2_HUMAN	Disease (PS)	---	F	A	344	P
42	UniProt	VAR_004142	S	347	C	FGFR2_HUMAN	Disease (CS)	121918494	F	S	347	C
43	UniProt	VAR_004143	S	351	C	FGFR2_HUMAN	Disease (PS)	121918502	F	S	351	C
44	UniProt	VAR_004144	S	354	C	FGFR2_HUMAN	Disease (CS)	121918490	F	S	354	C
45	UniProt	VAR_017272	S	354	Y	FGFR2_HUMAN	Disease (CS)	---	F	S	354	Y
46	UniProt	VAR_004146	V	359	F	FGFR2_HUMAN	Disease (PS)	---	F	V	359	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 3 (47, 47)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017259	A	172	F	FGFR2_HUMAN	Disease (PS)	---	G	A	172	F
02	UniProt	VAR_017260	M	186	T	FGFR2_HUMAN	Polymorphism	755793	G	M	186	T
03	UniProt	VAR_036380	R	203	C	FGFR2_HUMAN	Unclassified	---	G	R	203	C
04	UniProt	VAR_004114	S	252	F	FGFR2_HUMAN	Disease (APRS)	121918498	G	S	252	F
05	UniProt	VAR_004113	S	252	L	FGFR2_HUMAN	Disease (CS)	79184941	G	S	252	L
06	UniProt	VAR_004115	S	252	W	FGFR2_HUMAN	Disease (PS)	79184941	G	S	252	W
07	UniProt	VAR_004117	P	253	R	FGFR2_HUMAN	Disease (APRS)	77543610	G	R	253	R
08	UniProt	VAR_017261	P	263	L	FGFR2_HUMAN	Disease (CS)	779326224	G	P	263	L
09	UniProt	VAR_004118	S	267	P	FGFR2_HUMAN	Disease (CS)	121918505	G	S	267	P
10	UniProt	VAR_042205	G	272	V	FGFR2_HUMAN	Unclassified	---	G	G	272	V
11	UniProt	VAR_004120	F	276	V	FGFR2_HUMAN	Disease (CS)	---	G	F	276	V
12	UniProt	VAR_004121	C	278	F	FGFR2_HUMAN	Disease (PS)	776587763	G	C	278	F
13	UniProt	VAR_017263	C	278	Y	FGFR2_HUMAN	Disease (CS)	---	G	C	278	Y
14	UniProt	VAR_017264	Y	281	C	FGFR2_HUMAN	Disease (CS)	---	G	Y	281	C
15	UniProt	VAR_042206	D	283	N	FGFR2_HUMAN	Unclassified	---	G	D	283	N
16	UniProt	VAR_017265	I	288	S	FGFR2_HUMAN	Disease (CS)	---	G	I	288	S
17	UniProt	VAR_004123	Q	289	P	FGFR2_HUMAN	Disease (JWS)	121918497	G	Q	289	P
18	UniProt	VAR_004124	W	290	C	FGFR2_HUMAN	Disease (PS)	121918499	G	W	290	C
19	UniProt	VAR_017266	W	290	G	FGFR2_HUMAN	Disease (CS)	121918501	G	W	290	G
20	UniProt	VAR_004125	W	290	R	FGFR2_HUMAN	Disease (CS)	121918501	G	W	290	R
21	UniProt	VAR_004126	K	292	E	FGFR2_HUMAN	Disease (CS)	121918500	G	K	292	E
22	UniProt	VAR_004127	Y	301	C	FGFR2_HUMAN	Disease (CS)	---	G	Y	301	C
23	UniProt	VAR_004128	A	314	S	FGFR2_HUMAN	Unclassified	---	G	A	314	S
24	UniProt	VAR_017267	A	315	S	FGFR2_HUMAN	Polymorphism	121918504	G	A	315	S
25	UniProt	VAR_004129	D	321	A	FGFR2_HUMAN	Disease (PS)	121918510	G	D	321	A
26	UniProt	VAR_004130	Y	328	C	FGFR2_HUMAN	Disease (CS)	121918493	G	Y	328	C
27	UniProt	VAR_004131	N	331	I	FGFR2_HUMAN	Disease (CS)	---	G	N	331	I
28	UniProt	VAR_017268	A	337	P	FGFR2_HUMAN	Disease (CS)	387906676	G	A	337	P
29	UniProt	VAR_004133	G	338	E	FGFR2_HUMAN	Disease (CS)	---	G	G	338	E
30	UniProt	VAR_015011	G	338	R	FGFR2_HUMAN	Disease (CS)	---	G	G	338	R
31	UniProt	VAR_017269	Y	340	C	FGFR2_HUMAN	Disease (PS)	---	G	Y	340	C
32	UniProt	VAR_004134	Y	340	H	FGFR2_HUMAN	Disease (CS)	121918489	G	Y	340	H
33	UniProt	VAR_004135	T	341	P	FGFR2_HUMAN	Disease (PS)	121918495	G	T	341	P
34	UniProt	VAR_004136	C	342	F	FGFR2_HUMAN	Disease (CS)	---	G	C	342	F
35	UniProt	VAR_017270	C	342	G	FGFR2_HUMAN	Disease (PS)	---	G	C	342	G
36	UniProt	VAR_004137	C	342	R	FGFR2_HUMAN	Disease (PS)	121918488	G	C	342	R
37	UniProt	VAR_004138	C	342	S	FGFR2_HUMAN	Disease (PS)	121918488	G	C	342	S
38	UniProt	VAR_017271	C	342	W	FGFR2_HUMAN	Disease (CS)	121918496	G	C	342	W
39	UniProt	VAR_004139	C	342	Y	FGFR2_HUMAN	Disease (PS)	121918487	G	C	342	Y
40	UniProt	VAR_004140	A	344	G	FGFR2_HUMAN	Disease (JWS)	121918492	G	A	344	G
41	UniProt	VAR_004141	A	344	P	FGFR2_HUMAN	Disease (PS)	---	G	A	344	P
42	UniProt	VAR_004142	S	347	C	FGFR2_HUMAN	Disease (CS)	121918494	G	S	347	C
43	UniProt	VAR_004143	S	351	C	FGFR2_HUMAN	Disease (PS)	121918502	G	S	351	C
44	UniProt	VAR_004144	S	354	C	FGFR2_HUMAN	Disease (CS)	121918490	G	S	354	C
45	UniProt	VAR_017272	S	354	Y	FGFR2_HUMAN	Disease (CS)	---	G	S	354	Y
46	UniProt	VAR_004146	V	359	F	FGFR2_HUMAN	Disease (PS)	---	G	V	359	F
47	UniProt	VAR_017273	A	362	S	FGFR2_HUMAN	Disease (CS)	---	G	A	362	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 4 (47, 47)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017259	A	172	F	FGFR2_HUMAN	Disease (PS)	---	H	A	172	F
02	UniProt	VAR_017260	M	186	T	FGFR2_HUMAN	Polymorphism	755793	H	M	186	T
03	UniProt	VAR_036380	R	203	C	FGFR2_HUMAN	Unclassified	---	H	R	203	C
04	UniProt	VAR_004114	S	252	F	FGFR2_HUMAN	Disease (APRS)	121918498	H	S	252	F
05	UniProt	VAR_004113	S	252	L	FGFR2_HUMAN	Disease (CS)	79184941	H	S	252	L
06	UniProt	VAR_004115	S	252	W	FGFR2_HUMAN	Disease (PS)	79184941	H	S	252	W
07	UniProt	VAR_004117	P	253	R	FGFR2_HUMAN	Disease (APRS)	77543610	H	R	253	R
08	UniProt	VAR_017261	P	263	L	FGFR2_HUMAN	Disease (CS)	779326224	H	P	263	L
09	UniProt	VAR_004118	S	267	P	FGFR2_HUMAN	Disease (CS)	121918505	H	S	267	P
10	UniProt	VAR_042205	G	272	V	FGFR2_HUMAN	Unclassified	---	H	G	272	V
11	UniProt	VAR_004120	F	276	V	FGFR2_HUMAN	Disease (CS)	---	H	F	276	V
12	UniProt	VAR_004121	C	278	F	FGFR2_HUMAN	Disease (PS)	776587763	H	C	278	F
13	UniProt	VAR_017263	C	278	Y	FGFR2_HUMAN	Disease (CS)	---	H	C	278	Y
14	UniProt	VAR_017264	Y	281	C	FGFR2_HUMAN	Disease (CS)	---	H	Y	281	C
15	UniProt	VAR_042206	D	283	N	FGFR2_HUMAN	Unclassified	---	H	D	283	N
16	UniProt	VAR_017265	I	288	S	FGFR2_HUMAN	Disease (CS)	---	H	I	288	S
17	UniProt	VAR_004123	Q	289	P	FGFR2_HUMAN	Disease (JWS)	121918497	H	Q	289	P
18	UniProt	VAR_004124	W	290	C	FGFR2_HUMAN	Disease (PS)	121918499	H	W	290	C
19	UniProt	VAR_017266	W	290	G	FGFR2_HUMAN	Disease (CS)	121918501	H	W	290	G
20	UniProt	VAR_004125	W	290	R	FGFR2_HUMAN	Disease (CS)	121918501	H	W	290	R
21	UniProt	VAR_004126	K	292	E	FGFR2_HUMAN	Disease (CS)	121918500	H	K	292	E
22	UniProt	VAR_004127	Y	301	C	FGFR2_HUMAN	Disease (CS)	---	H	Y	301	C
23	UniProt	VAR_004128	A	314	S	FGFR2_HUMAN	Unclassified	---	H	A	314	S
24	UniProt	VAR_017267	A	315	S	FGFR2_HUMAN	Polymorphism	121918504	H	A	315	S
25	UniProt	VAR_004129	D	321	A	FGFR2_HUMAN	Disease (PS)	121918510	H	D	321	A
26	UniProt	VAR_004130	Y	328	C	FGFR2_HUMAN	Disease (CS)	121918493	H	Y	328	C
27	UniProt	VAR_004131	N	331	I	FGFR2_HUMAN	Disease (CS)	---	H	N	331	I
28	UniProt	VAR_017268	A	337	P	FGFR2_HUMAN	Disease (CS)	387906676	H	A	337	P
29	UniProt	VAR_004133	G	338	E	FGFR2_HUMAN	Disease (CS)	---	H	G	338	E
30	UniProt	VAR_015011	G	338	R	FGFR2_HUMAN	Disease (CS)	---	H	G	338	R
31	UniProt	VAR_017269	Y	340	C	FGFR2_HUMAN	Disease (PS)	---	H	Y	340	C
32	UniProt	VAR_004134	Y	340	H	FGFR2_HUMAN	Disease (CS)	121918489	H	Y	340	H
33	UniProt	VAR_004135	T	341	P	FGFR2_HUMAN	Disease (PS)	121918495	H	T	341	P
34	UniProt	VAR_004136	C	342	F	FGFR2_HUMAN	Disease (CS)	---	H	C	342	F
35	UniProt	VAR_017270	C	342	G	FGFR2_HUMAN	Disease (PS)	---	H	C	342	G
36	UniProt	VAR_004137	C	342	R	FGFR2_HUMAN	Disease (PS)	121918488	H	C	342	R
37	UniProt	VAR_004138	C	342	S	FGFR2_HUMAN	Disease (PS)	121918488	H	C	342	S
38	UniProt	VAR_017271	C	342	W	FGFR2_HUMAN	Disease (CS)	121918496	H	C	342	W
39	UniProt	VAR_004139	C	342	Y	FGFR2_HUMAN	Disease (PS)	121918487	H	C	342	Y
40	UniProt	VAR_004140	A	344	G	FGFR2_HUMAN	Disease (JWS)	121918492	H	A	344	G
41	UniProt	VAR_004141	A	344	P	FGFR2_HUMAN	Disease (PS)	---	H	A	344	P
42	UniProt	VAR_004142	S	347	C	FGFR2_HUMAN	Disease (CS)	121918494	H	S	347	C
43	UniProt	VAR_004143	S	351	C	FGFR2_HUMAN	Disease (PS)	121918502	H	S	351	C
44	UniProt	VAR_004144	S	354	C	FGFR2_HUMAN	Disease (CS)	121918490	H	S	354	C
45	UniProt	VAR_017272	S	354	Y	FGFR2_HUMAN	Disease (CS)	---	H	S	354	Y
46	UniProt	VAR_004146	V	359	F	FGFR2_HUMAN	Disease (PS)	---	H	V	359	F
47	UniProt	VAR_017273	A	362	S	FGFR2_HUMAN	Disease (CS)	---	H	A	362	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (1, 4)

Exons (9, 34)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:134
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:134
                                   164       174       184       194       204       214       224       234       244       254       264       274       284    
           FGF2_HUMAN   155 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 288
               SCOP domains d1iila_ A: Basic FGF (FGF2)                                                                                                            SCOP domains
               CATH domains 1iilA00 A:22-155  [code=2.80.10.50, no name defined]                                                                                   CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ........eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee........eeeee.....eeeee.................hhhhh...hhhh.eeeee... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------HBGF_FGF  PDB: A:89-112 ------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1  PDB: A:22-60 UniProt: 1-193  ----------------------------------Exon 1.3b  PDB: A:95-155 UniProt: 228-288                     Transcript 1 (1)
           Transcript 1 (2) --------------------------------------Exon 1.2  PDB: A:60-94             ------------------------------------------------------------- Transcript 1 (2)
                 1iil A  22 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 155
                                    31        41        51        61        71        81        91       101       111       121       131       141       151

Chain B from PDB  Type:PROTEIN  Length:133
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:133
                                   164       174       184       194       204       214       224       234       244       254       264       274       284   
           FGF2_HUMAN   155 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 287
               SCOP domains d1iilb_ B: Basic FGF (FGF2)                                                                                                           SCOP domains
               CATH domains 1iilB00 B:22-154  [code=2.80.10.50, no name defined]                                                                                  CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ........eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee........eeeee.....eeeee.................hhhhh...hhhh.eeeee.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------HBGF_FGF  PDB: B:89-112 ------------------------------------------ PROSITE
           Transcript 1 (1) Exon 1.1  PDB: B:22-60 UniProt: 1-193  ----------------------------------Exon 1.3b  PDB: B:95-154 UniProt: 228-288 [INCOMPLETE]       Transcript 1 (1)
           Transcript 1 (2) --------------------------------------Exon 1.2  PDB: B:60-94             ------------------------------------------------------------ Transcript 1 (2)
                 1iil B  22 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 154
                                    31        41        51        61        71        81        91       101       111       121       131       141       151

Chain C from PDB  Type:PROTEIN  Length:132
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:132
                                   166       176       186       196       206       216       226       236       246       256       266       276       286  
           FGF2_HUMAN   157 GHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 288
               SCOP domains d1iilc_ C: Basic FGF (FGF2)                                                                                                          SCOP domains
               CATH domains 1iilC00 C:24-155  [code=2.80.10.50, no name defined]                                                                                 CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ......eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee...hhhh.eeeee.....eeeee.................hhhhh...hhhh.eeeee... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE -----------------------------------------------------------------HBGF_FGF  PDB: C:89-112 ------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1  PDB: C:24-60 UniProt: 1-193----------------------------------Exon 1.3b  PDB: C:95-155 UniProt: 228-288                     Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.2  PDB: C:60-94             ------------------------------------------------------------- Transcript 1 (2)
                 1iil C  24 GHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 155
                                    33        43        53        63        73        83        93       103       113       123       133       143       153

Chain D from PDB  Type:PROTEIN  Length:132
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:132
                                   165       175       185       195       205       215       225       235       245       255       265       275       285  
           FGF2_HUMAN   156 PGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 287
               SCOP domains d1iild_ D: Basic FGF (FGF2)                                                                                                          SCOP domains
               CATH domains 1iilD00 D:23-154  [code=2.80.10.50, no name defined]                                                                                 CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .......eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee...hhhh.eeeee.....eeeee.................hhhhh...hhhh.eeeee.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------HBGF_FGF  PDB: D:89-112 ------------------------------------------ PROSITE
           Transcript 1 (1) Exon 1.1  PDB: D:23-60 UniProt: 1-193 ----------------------------------Exon 1.3b  PDB: D:95-154 UniProt: 228-288 [INCOMPLETE]       Transcript 1 (1)
           Transcript 1 (2) -------------------------------------Exon 1.2  PDB: D:60-94             ------------------------------------------------------------ Transcript 1 (2)
                 1iil D  23 PGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 154
                                    32        42        52        62        72        82        92       102       112       122       132       142       152

Chain E from PDB  Type:PROTEIN  Length:200
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:212
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359  
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
               SCOP domains d1iile1 E:150-250 Fibroblast growth factor receptor, FGFR                                            d1iile2 E:251-361 Fibroblast growth factor r            eceptor, FGFR                                           SCOP domains
               CATH domains 1iilE01 E:150-250 Immunoglobulins                                                                    1iilE02 E:251-357 Immunoglobulins                                                                          ---- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee.------------..eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E---------------------SS-----A------C--I-----PE-CPF-G--C---C--C----F-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y------------------- SAPs(SNPs) (6)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: E:250-313 (gaps) UniProt: 250-313               Exon 2.18b  PDB: E:314-361 UniProt: 314-362      Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: E:152-208 UniProt: 152-208                Exon 2.8  PDB: E:209-250 UniProt: 209-250 --------------------------------------------------------------------------------------------------------------- Transcript 2 (2)
                 1iil E 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHV------------PYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289    |    -       309       319       329       339       349       359  
                                                                                                                                                                          294          307

Chain F from PDB  Type:PROTEIN  Length:200
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:212
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359  
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
               SCOP domains d1iilf1 F:150-250 Fibroblast growth factor receptor, FGFR                                            d1iilf2 F:251-361 Fibroblast growth factor r            eceptor, FGFR                                           SCOP domains
               CATH domains 1iilF01 F:150-250 Immunoglobulins                                                                    1iilF02 F:251-357 Immunoglobulins                                                                          ---- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee.------------..eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E---------------------SS-----A------C--I-----PE-CPF-G--C---C--C----F-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y------------------- SAPs(SNPs) (6)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: F:250-313 (gaps) UniProt: 250-313               Exon 2.18b  PDB: F:314-361 UniProt: 314-362      Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: F:152-208 UniProt: 152-208                Exon 2.8  PDB: F:209-250 UniProt: 209-250 --------------------------------------------------------------------------------------------------------------- Transcript 2 (2)
                 1iil F 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHV------------PYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289    |    -       309       319       329       339       349       359  
                                                                                                                                                                          294          307

Chain G from PDB  Type:PROTEIN  Length:215
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:215
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359     
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
               SCOP domains d1iilg1 G:150-250 Fibroblast growth factor receptor, FGFR                                            d1iilg2 G:251-364 Fibroblast growth factor receptor, FGFR                                                          SCOP domains
               CATH domains 1iilG01 G:150-250 Immunoglobulins                                                                    1iilG02 G:251-357 Immunoglobulins                                                                          ------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee...............eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee.... Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E--------C------------SS-----A------C--I-----PE-CPF-G--C---C--C----F--S-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y---------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R---------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S---------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W---------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y---------------------- SAPs(SNPs) (6)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: G:250-313 UniProt: 250-313                      Exon 2.18b  PDB: G:314-362 UniProt: 314-362      -- Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: G:152-208 UniProt: 152-208                Exon 2.8  PDB: G:209-250 UniProt: 209-250 ---------------------------------------------------------------------------------------------------------------2.1 Transcript 2 (2)
                 1iil G 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359

Chain H from PDB  Type:PROTEIN  Length:215
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:215
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359     
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
               SCOP domains d1iilh1 H:150-250 Fibroblast growth factor receptor, FGFR                                            d1iilh2 H:251-364 Fibroblast growth factor receptor, FGFR                                                          SCOP domains
               CATH domains 1iilH01 H:150-250 Immunoglobulins                                                                    1iilH02 H:251-357 Immunoglobulins                                                                          ------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee...............eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee.... Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E--------C------------SS-----A------C--I-----PE-CPF-G--C---C--C----F--S-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y---------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R---------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S---------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W---------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y---------------------- SAPs(SNPs) (6)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: H:250-313 UniProt: 250-313                      Exon 2.18b  PDB: H:314-362 UniProt: 314-362      -- Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: H:152-208 UniProt: 152-208                Exon 2.8  PDB: H:209-250 UniProt: 209-250 ---------------------------------------------------------------------------------------------------------------2.1 Transcript 2 (2)
                 1iil H 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (2, 12)

CATH Domains (2, 12)

Pfam Domains (0, 0)

Gene Ontology (176, 199)

Asymmetric Unit(hide GO term definitions)

Chain A,B,C,D (FGF2_HUMAN | P09038)

molecular function
	GO:0016303	1-phosphatidylinositol-3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0042056	chemoattractant activity	Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
	GO:0005125	cytokine activity	Functions to control the survival, growth, differentiation and effector function of tissues and cells.
	GO:0005104	fibroblast growth factor receptor binding	Interacting selectively and non-covalently with the fibroblast growth factor receptor (FGFR).
	GO:0008083	growth factor activity	The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	The function of a transcription cofactor that activates transcription in conjuction with a ligand-dependent nuclear receptor from a RNA polymerase II promoter; does not bind DNA itself.
	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0007265	Ras protein signal transduction	A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
	GO:0000187	activation of MAPK activity	The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
	GO:0001525	angiogenesis	Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
	GO:0009887	animal organ morphogenesis	Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
	GO:0001658	branching involved in ureteric bud morphogenesis	The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
	GO:0030154	cell differentiation	The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
	GO:0002042	cell migration involved in sprouting angiogenesis	The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
	GO:0006935	chemotaxis	The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
	GO:0060591	chondroblast differentiation	The process in which a mesenchymal cell, acquires specialized structural and/or functional features of a chondroblast. Differentiation includes the processes involved in commitment of a cell to a chondroblast fate. A chondroblast is a precursor cell to chondrocytes.
	GO:0048598	embryonic morphogenesis	The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
	GO:0030198	extracellular matrix organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
	GO:0008543	fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
	GO:0014843	growth factor dependent regulation of skeletal muscle satellite cell proliferation	Any process that modulates the frequency, rate or extent of satellite cell proliferation; dependent on specific growth factor activity such as fibroblast growth factors and transforming growth factor beta.
	GO:0030214	hyaluronan catabolic process	The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
	GO:0032958	inositol phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.
	GO:0007275	multicellular organism development	The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
	GO:0043537	negative regulation of blood vessel endothelial cell migration	Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
	GO:0060548	negative regulation of cell death	Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
	GO:0010764	negative regulation of fibroblast migration	Any process that decreases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
	GO:0061045	negative regulation of wound healing	Any process that decreases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
	GO:0007399	nervous system development	The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0006661	phosphatidylinositol biosynthetic process	The chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
	GO:0046854	phosphatidylinositol phosphorylation	The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0050918	positive chemotaxis	The directed movement of a motile cell or organism towards a higher concentration of a chemical.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0043406	positive regulation of MAP kinase activity	Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
	GO:0045766	positive regulation of angiogenesis	Any process that activates or increases angiogenesis.
	GO:0043536	positive regulation of blood vessel endothelial cell migration	Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
	GO:0060045	positive regulation of cardiac muscle cell proliferation	Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
	GO:0051781	positive regulation of cell division	Any process that activates or increases the frequency, rate or extent of cell division.
	GO:0042660	positive regulation of cell fate specification	Any process that activates or enables a cell to adopt a specific fate.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
	GO:0001938	positive regulation of endothelial cell proliferation	Any process that activates or increases the rate or extent of endothelial cell proliferation.
	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
	GO:0010863	positive regulation of phospholipase C activity	Any process that increases the rate of phospholipase C activity.
	GO:1903672	positive regulation of sprouting angiogenesis	Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0045893	positive regulation of transcription, DNA-templated	Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0045765	regulation of angiogenesis	Any process that modulates the frequency, rate or extent of angiogenesis.
	GO:2000544	regulation of endothelial cell chemotaxis to fibroblast growth factor	Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0051209	release of sequestered calcium ion into cytosol	The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0035019	somatic stem cell population maintenance	Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
	GO:0042060	wound healing	The series of events that restore integrity to a damaged tissue, following an injury.
cellular component
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Chain E,F,G,H (FGFR2_HUMAN | P21802)

molecular function
	GO:0016303	1-phosphatidylinositol-3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0017134	fibroblast growth factor binding	Interacting selectively and non-covalently with a fibroblast growth factor.
	GO:0005007	fibroblast growth factor-activated receptor activity	Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0001525	angiogenesis	Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
	GO:0009887	animal organ morphogenesis	Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
	GO:0006915	apoptotic process	A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
	GO:0007409	axonogenesis	De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon.
	GO:0060348	bone development	The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
	GO:0030282	bone mineralization	The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
	GO:0060349	bone morphogenesis	The process in which bones are generated and organized.
	GO:0060667	branch elongation involved in salivary gland morphogenesis	The differential growth of the salivary branches along their axis, resulting in the growth of a branch.
	GO:0060670	branching involved in labyrinthine layer morphogenesis	The process in which the branches of the fetal placental villi are generated and organized. The villous part of the placenta is called the labyrinth layer.
	GO:0060442	branching involved in prostate gland morphogenesis	The process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
	GO:0060445	branching involved in salivary gland morphogenesis	The process in which the branching structure of the salivary gland is generated and organized.
	GO:0048755	branching morphogenesis of a nerve	The process in which the anatomical structures of branches in a nerve are generated and organized. This term refers to an anatomical structure (nerve) not a cell (neuron).
	GO:0060449	bud elongation involved in lung branching	The process in which a bud in the lung grows out from the point where it is formed.
	GO:0045165	cell fate commitment	The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
	GO:0007267	cell-cell signaling	Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
	GO:0048565	digestive tract development	The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
	GO:0048701	embryonic cranial skeleton morphogenesis	The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
	GO:0048557	embryonic digestive tract morphogenesis	The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed.
	GO:0048568	embryonic organ development	Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
	GO:0048562	embryonic organ morphogenesis	Morphogenesis, during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
	GO:0009880	embryonic pattern specification	The process that results in the patterns of cell differentiation that will arise in an embryo.
	GO:0048730	epidermis morphogenesis	The process in which the anatomical structures of the epidermis are generated and organized. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
	GO:0030855	epithelial cell differentiation	The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
	GO:0060664	epithelial cell proliferation involved in salivary gland morphogenesis	The multiplication or reproduction of epithelial cells of the submandibular salivary gland, resulting in the expansion of a cell population and the shaping of the gland.
	GO:0001837	epithelial to mesenchymal transition	A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
	GO:0008543	fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
	GO:0035603	fibroblast growth factor receptor signaling pathway involved in hemopoiesis	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which contributes to hemopoiesis.
	GO:0060595	fibroblast growth factor receptor signaling pathway involved in mammary gland specification	The series of molecular signals initiated by binding of a fibroblast growth factor to its receptor on the surface of al cell in the epidermis resulting in the formation of the mammary line. The mammary line is a ridge of epidermal cells that will form the mammary placodes.
	GO:0035602	fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.
	GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
	GO:0035604	fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.
	GO:0022612	gland morphogenesis	The process in which the anatomical structures of a gland are generated and organized.
	GO:0031069	hair follicle morphogenesis	The process in which the anatomical structures of the hair follicle are generated and organized.
	GO:0001701	in utero embryonic development	The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
	GO:0042472	inner ear morphogenesis	The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
	GO:0032808	lacrimal gland development	The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.
	GO:0060601	lateral sprouting from an epithelium	The process in which a branch forms along the side of an epithelium.
	GO:0060174	limb bud formation	The process pertaining to the initial formation of a limb bud from unspecified parts. This process begins with the formation of a local condensation of mesenchyme cells within the prospective limb field, and ends when a limb bud is recognizable.
	GO:0048286	lung alveolus development	The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
	GO:0030324	lung development	The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
	GO:0060463	lung lobe morphogenesis	The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
	GO:0060484	lung-associated mesenchyme development	The biological process whose specific outcome is the progression of a lung-associated mesenchyme from an initial condition to its mature state. This process begins with the formation of lung-associated mesenchyme and ends with the mature structure. Lung-associated mesenchyme is the tissue made up of loosely connected mesenchymal cells in the lung.
	GO:0060615	mammary gland bud formation	The morphogenetic process in which a bud forms from the mammary placode. A mammary bud is bulb of epithelial cells that is distinct from the surrounding epidermis.
	GO:0003149	membranous septum morphogenesis	The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
	GO:0048762	mesenchymal cell differentiation	The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
	GO:0060915	mesenchymal cell differentiation involved in lung development	The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell of the lung. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
	GO:0060916	mesenchymal cell proliferation involved in lung development	The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population that contributes to the progression of the lung over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
	GO:0048333	mesodermal cell differentiation	The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
	GO:0030901	midbrain development	The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
	GO:0016331	morphogenesis of embryonic epithelium	The process in which the anatomical structures of embryonic epithelia are generated and organized.
	GO:0035264	multicellular organism growth	The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
	GO:0050680	negative regulation of epithelial cell proliferation	Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0042476	odontogenesis	The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
	GO:0021769	orbitofrontal cortex development	The progression of the orbitofrontal cortex over time from its initial formation until its mature state. The orbitofrontal cortex is a cerebral cortex region located in the frontal lobe.
	GO:0035265	organ growth	The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
	GO:0030916	otic vesicle formation	The process resulting in the transition of the otic placode into the otic vesicle, a transient embryonic structure formed during development of the vertebrate inner ear.
	GO:0003148	outflow tract septum morphogenesis	The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0046854	phosphatidylinositol phosphorylation	The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0043410	positive regulation of MAPK cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
	GO:0030177	positive regulation of Wnt signaling pathway	Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
	GO:0090263	positive regulation of canonical Wnt signaling pathway	Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
	GO:0060045	positive regulation of cardiac muscle cell proliferation	Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
	GO:0045787	positive regulation of cell cycle	Any process that activates or increases the rate or extent of progression through the cell cycle.
	GO:0051781	positive regulation of cell division	Any process that activates or increases the frequency, rate or extent of cell division.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:0050679	positive regulation of epithelial cell proliferation	Any process that activates or increases the rate or extent of epithelial cell proliferation.
	GO:0060501	positive regulation of epithelial cell proliferation involved in lung morphogenesis	Any process that increases the rate or frequency of epithelial cell proliferation that results in the lung attaining its shape.
	GO:0002053	positive regulation of mesenchymal cell proliferation	The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
	GO:0010518	positive regulation of phospholipase activity	Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
	GO:0048661	positive regulation of smooth muscle cell proliferation	Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0009791	post-embryonic development	The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	The branching morphogenesis process in which the prostate epithelial cords branch freely to create the structure of the prostate acini.
	GO:0060523	prostate epithelial cord elongation	The developmental growth process in which solid chords of prostate epithelium increase in length.
	GO:0060512	prostate gland morphogenesis	The process in which the anatomical structures of a prostate gland are generated and organized.
	GO:0046777	protein autophosphorylation	The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0021860	pyramidal neuron development	The progression of a pyramidal neuron from its initial formation to its mature state.
	GO:0070372	regulation of ERK1 and ERK2 cascade	Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0060687	regulation of branching involved in prostate gland morphogenesis	Any process that modulates the rate, frequency, or extent of prostate gland branching, the process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
	GO:0010453	regulation of cell fate commitment	Any process that modulates the frequency, rate or extent of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
	GO:0060688	regulation of morphogenesis of a branching structure	Any process that modulates the rate, frequency, or extent of branching morphogenesis, the process in which the anatomical structures of branches are generated and organized.
	GO:0040014	regulation of multicellular organism growth	Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
	GO:0045667	regulation of osteoblast differentiation	Any process that modulates the frequency, rate or extent of osteoblast differentiation.
	GO:0033688	regulation of osteoblast proliferation	Any process that modulates the frequency, rate or extent of osteoblast proliferation.
	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0051150	regulation of smooth muscle cell differentiation	Any process that modulates the frequency, rate or extent of smooth muscle cell differentiation.
	GO:0008589	regulation of smoothened signaling pathway	Any process that modulates the frequency, rate or extent of smoothened signaling.
	GO:0048608	reproductive structure development	The reproductive developmental process whose specific outcome is the progression of structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures.
	GO:0048705	skeletal system morphogenesis	The process in which the anatomical structures of the skeleton are generated and organized.
	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	The process in which a relatively unspecialized epithelial cell acquires specialized features of a squamous basal epithelial stem cell of the prostate.
	GO:0001657	ureteric bud development	The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
	GO:0055010	ventricular cardiac muscle tissue morphogenesis	The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
	GO:0021847	ventricular zone neuroblast division	The proliferation of neuroblasts in the ventricular zone of the cerebral cortex. The neuronal progenitors of these cells will migrate radially.
cellular component
	GO:0005794	Golgi apparatus	A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
	GO:0005938	cell cortex	The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0031410	cytoplasmic vesicle	A vesicle found in the cytoplasm of a cell.
	GO:0060076	excitatory synapse	A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell.
	GO:0031012	extracellular matrix	A structure lying external to one or more cells, which provides structural support for cells or tissues.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0043231	intracellular membrane-bounded organelle	Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (0, 0)

Sites (0, 0)

SS Bonds (8, 8)

Cis Peptide Bonds (8, 8)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (47, 184)

PROSITE Motifs (1, 4)

Exons (9, 34)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 12)

CATH Domains (2, 12)

Pfam Domains (0, 0)

Gene Ontology (176, 199)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File